Justin A. Renz
2016
In 2016, Justin A. Renz earned a total compensation of $931.6K as Former Executive Vice President, Chief Financial Officer & Treasurer at Karyopharm Therapeutics, a 50% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $114,100 |
|---|---|
| Option Awards | $446,190 |
| Salary | $360,000 |
| Other | $11,260 |
| Total | $931,550 |
Renz received $446.2K in option awards, accounting for 48% of the total pay in 2016.
Renz also received $114.1K in non-equity incentive plan, $360K in salary and $11.3K in other compensation.
Rankings
In 2016, Justin A. Renz's compensation ranked 8,579th out of 14,075 executives tracked by ExecPay. In other words, Renz earned more than 39.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,579 out of 14,075 | 39th |
Division Manufacturing | 3,302 out of 5,489 | 40th |
Major group Chemicals And Allied Products | 1,114 out of 1,895 | 41st |
Industry group Drugs | 871 out of 1,538 | 43rd |
Industry Pharmaceutical Preparations | 691 out of 1,176 | 41st |
Source: SEC filing on April 28, 2017.
Renz's colleagues
We found three more compensation records of executives who worked with Justin A. Renz at Karyopharm Therapeutics in 2016.